首页> 外文期刊>Emerging Infectious Diseases >Echinococcoses and Tibetan Communities
【24h】

Echinococcoses and Tibetan Communities

机译:棘球菌和藏族社区

获取原文
获取外文期刊封面目录资料

摘要

To the Editor: The People's Re-public of China accounts for >500,000 cases of echinococcosis and more dis-ability-associated life years (DALYs) lost because of this disease than any other world region (1,2). Hydatid cysts of Echinococcus granulosus (cystic echinococcosis [CE]), or the more pathogenic lesions with mul-tiple vesicles caused by E. multilocu-laris infection (alveolar echinococ-cosis [AE]), usually grow slowly in the liver, so that severe illness and death may eventually occur in a high proportion of those with untreated infections (3,4). Apart from surgery, long-term anthelminthic therapy (>6 months) with the benzimidazole com-pound albendazole, although parasito-static only, has a benefi cial outcome in >50% of cases (5). To control the transmission of this zoonosis, veteri-nary public health measures must be emphasized (6).
机译:致编辑:中华人民共和国因这种疾病而导致的埃希菌球菌病病例超过500,000例,与残疾相关的生命年(DALYs)损失比世界任何其他地区都多(1,2)。粒状棘球E虫的包虫囊肿(囊性棘球co虫病[CE]),或由多部位大肠杆菌感染引起的多囊泡的病原性病变多(肺泡棘球[病[AE]),通常在肝脏中缓慢生长,因此严重的疾病和死亡最终可能会在未经治疗的感染中占很高的比例(3,4)。除手术外,使用苯并咪唑复方阿苯达唑进行长期驱虫治疗(> 6个月),尽管仅具有抗寄生虫作用,但在> 50%的病例中有良好的预后(5)。为了控制这种人畜共患病的传播,必须强调兽医公共卫生措施(6)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号